FDA approves Greenwich’s marijuana-derived drug for seizures

This article was originally published here

Greenwich Biosciences, a subsidiary of UK-based GW Pharmaceuticals has secured approval from the US Food and Drug Administration (FDA) for the Epidiolex (cannabidiol) oral solution to treat seizures associated with two severe childhood-onset epilepsies.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply